8-K/A: Prestige Consumer Healthcare Completes Brand Acquisition

Prestige Consumer Healthcare Inc. files an amended 8-K to clarify financial statements related to its acquisition of the Breathe Right and other brands from Foundation Consumer Brands, LLC.

Summary

• This filing is an amendment to a previous 8-K report, specifically to correct an inadvertent inclusion of an auditor's review report.
• The original 8-K reported the completion of the acquisition of the 'OTC Wellness Business' (including brands like Breathe Right, Dimetapp, Anbesol, etc.) from Foundation Consumer Brands, LLC on June 12, 2026.
• The amendment provides unaudited condensed combined financial statements for the acquired OTC Wellness Business as of March 31, 2026, and for the three months ended March 31, 2026 and 2025.
• The financial statements show net sales of $51.7 million for the three months ended March 31, 2026, compared to $50.5 million for the same period in 2025.
• Income from operations for the three months ended March 31, 2026, was $12.6 million, a decrease from $14.8 million in the prior year period.
• Net income for the three months ended March 31, 2026, was $12.6 million, down from $14.8 million in the prior year period.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the reported decrease in income from operations and net income for the acquired business, despite a slight increase in net sales.

Positives

• The acquisition of the OTC Wellness Business, including well-known brands, has been completed.
• Net sales for the acquired business increased slightly to $51.7 million for the three months ended March 31, 2026, from $50.5 million in the prior year period.
• The company has provided detailed financial statements for the acquired business, allowing for a clearer understanding of its performance.

Negatives

• Income from operations for the acquired business decreased to $12.6 million for the three months ended March 31, 2026, from $14.8 million in the prior year period.
• Net income for the acquired business also decreased to $12.6 million for the three months ended March 31, 2026, from $14.8 million in the prior year period.
• Intangible assets, net, decreased from $335.6 million at December 31, 2025, to $328.3 million at March 31, 2026.
• Inventories, net, decreased from $17.5 million at December 31, 2025, to $14.5 million at March 31, 2026.

Risks

• The financial statements are presented on a combined basis and may not be representative of the results that would have been achieved if the OTC Wellness Business had operated independently.
• The acquired business relies on third-party manufacturers for product production and outsources warehousing and distribution.
• Concentrations of risk exist with three customers representing approximately 16%, 15%, and 13% of gross sales for the three months ended March 31, 2026.
• Two customers represented approximately 19% and 19% of accounts receivable as of March 31, 2026.

Future Outlook

The condensed combined results of operations for the three months ended March 31, 2026, are not necessarily indicative of the results to be expected for the full year ending December 31, 2026, or any other period.

Industry Context

StockSavvy.ai notes that the acquisition of established brands like Breathe Right and Dimetapp by Prestige Consumer Healthcare aligns with industry trends of consolidation and portfolio expansion within the consumer health sector, particularly in over-the-counter wellness products.

Legal Proceedings

• Management believes any liability from lawsuits arising in the ordinary course of business would not be material.
• There is no pending or threatened litigation against FCB related to the operations of the OTC Wellness Business or its employees as of March 31, 2026.

Related Party Transactions

• Advisory agreements with two affiliates provided consulting and advisory services to the Business, with allocated payments recorded in other expenses, net.
• Payments to Affiliate 1 were $101,000 for the three months ended March 31, 2026, down from $211,000 in the prior year.
• Payments to Affiliate 2 were $15,000 for the three months ended March 31, 2026, with no comparable figure for the prior year period (implied to be $0 or not applicable).

Stakeholder Impact

• Shareholders may be concerned by the decrease in profitability of the acquired business segment.
• Customers will continue to have access to the acquired brands, with operations managed through third-party logistics.
• Suppliers may see changes in payment terms or volumes based on the new ownership structure, though specific impacts are not detailed.

Key Dates

Recommendation

The filing provides updated financial information for an acquired business segment, showing a slight increase in revenue but a concerning decrease in profitability. While the acquisition itself is a strategic move, the immediate financial performance of the acquired assets warrants a cautious 'hold' stance until further operational improvements or integration benefits are evident.

Keywords

Prestige Consumer Healthcare, 8-K/A, Acquisition, OTC Wellness Business, Breathe Right, Foundation Consumer Brands, Financial Statements, Asset Purchase Agreement, Consumer Health